Quick Takeaways
- David E. Lazar filed SCHEDULE 13D/A for NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY).
- Disclosed ownership: 5%.
- Date of event: 21 Oct 2025.
David E. Lazar - 21 Oct 2025 SCHEDULE 13D/A Report for NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY)
- Filing Manager
- David E. Lazar
- Reporting Manager
- David E. Lazar
- Symbol
- NBY
- Shares outstanding
- 128,016,032 shares
- Disclosed Ownership
- 6,388,000 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13D/A
- Filing time
- 29 Jan 2026, 19:38:30 UTC
- Date of event
- 21 Oct 2025
- Previous filing
- 17 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"David E. Lazar disclosed 5% ownership in NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY) on 21 Oct 2025."
What Changed
- Previous schedule filing date: 17 Oct 2025.
- Current filing was accepted on 29 Jan 2026, 19:38.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| David E. Lazar | 5% | 6,388,000 | 6,388,000 | 0 | /s/ David E. Lazar | David E. Lazar | 0001932843 |